Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Jie Li
Shanxi Cancer Hospital
Taiyuan
China
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
95
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Randomized Controlled Trial of Irinotecan Plus S-1 for Pretreated Patients with Advanced Esophageal Squamous Cell Carcinoma
Number of pages: 66
Posted: 24 Sep 2018
Jing Huang
,
Binghe Xu
,
Ying Liu
,
Junxing Huang
,
Ping Lu
,
Yi Ba
,
Lin Wu
,
Yuxian Bai
,
Shu Zhang
,
Jifeng Feng
,
Ying Cheng
, Jie Li,
Lu Wen
,
Xianglin Yuan
,
Changwu Ma
,
Chunhong Hu
,
Qingxia Fan
and
Xi Wang
Chinese Academy of Medical Sciences - Cancer Hospital, Chinese Academy of Medical Sciences - Department of Medical Oncology, Zhengzhou University - Henan Cancer Hospital, Chinese Academy of Medical Sciences - Peking Union Medical College, Xinxiang Medical University - First Affiliated Hospital, Tianjin Cancer Hospital, Central South University - Hunan Cancer Hospital, Harbin Medical University - Cancer Hospital, Shandong University - Shandong Cancer Hospital, Nanjing Medical University - Jiangsu Institute of Cancer Research, Jilin Cancer Hospital, Shanxi Cancer Hospital, Shanxi Cancer Hospital, Huazhong University of Science and Technology - Department of Oncology, Chifeng Municipal Hospital, Central South University - Second Xiangya Hospital, Zhengzhou University - First Affiliated Hospital and Chinese Academy of Medical Sciences - Peking Union Medical College
Downloads
95
(715,072)
View PDF
Download
Abstract:
Esophageal Squamous Cell Carcinoma; Irinotecan; S-1
Feedback